Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Regulus outlines FDA requirements to reinitiate MAD studies with RGLS-4326

July 24, 2019

BioMarin Pharmaceutical identifies hydroxyacid oxidase 1 inhibitors

July 24, 2019

DiaMedica reports phase Ib interim data on DM-199 in chronic kidney disease

June 20, 2019

Arch Biopartners initiates phase I study of Metablok

June 20, 2019

Corvidia opens phase II study of ziltivekimab to reduce inflammation in chronic renal disease

June 14, 2019

RNA triad prevents dialysis-induced fibrosis

June 14, 2019

Increased CCL14 expression linked to chronic kidney disease

June 13, 2019

Positive topline results presented for phase II study of Gazyva in lupus nephritis

June 11, 2019

Goldfinch begins first-in-human study of GFB-887 for kidney disease

June 7, 2019

Allena Pharmaceuticals presents interim results from Study 206 of reloxaliase

June 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...